Literature DB >> 27476189

Dengue vaccine: WHO position paper – July 2016.

.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27476189

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  68 in total

1.  Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.

Authors:  Sven Verdonck; Szu-Yuan Pu; Fiona J Sorrell; Jon M Elkins; Mathy Froeyen; Ling-Jie Gao; Laura I Prugar; Danielle E Dorosky; Jennifer M Brannan; Rina Barouch-Bentov; Stefan Knapp; John M Dye; Piet Herdewijn; Shirit Einav; Steven De Jonghe
Journal:  J Med Chem       Date:  2019-06-12       Impact factor: 7.446

Review 2.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner.

Authors:  Scott B Halstead
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 3.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination.

Authors:  Stephen S Whitehead; Kanta Subbarao
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 4.  Using Wolbachia for Dengue Control: Insights from Modelling.

Authors:  Ilaria Dorigatti; Clare McCormack; Gemma Nedjati-Gilani; Neil M Ferguson
Journal:  Trends Parasitol       Date:  2017-11-25

5.  Cause and consequence of loss in vaccine trust.

Authors:  Antonio L Dans; Leonila F Dans; Maria Asuncion A Silvestre; Scott B Halstead; Gordon H Guyatt
Journal:  Hum Vaccin Immunother       Date:  2018-12-11       Impact factor: 3.452

6.  A lethal model of disseminated dengue virus type 1 infection in AG129 mice.

Authors:  Gregg N Milligan; Vanessa V Sarathy; Mellodee M White; M Banks Greenberg; Gerald A Campbell; Richard B Pyles; Alan D T Barrett; Nigel Bourne
Journal:  J Gen Virol       Date:  2017-09-27       Impact factor: 3.891

Review 7.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

8.  Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.

Authors:  Stephan T Kudlacek; Lakshmanane Premkumar; Stefan W Metz; Ashutosh Tripathy; Andrey A Bobkov; Alexander Matthew Payne; Stephen Graham; James A Brackbill; Michael J Miley; Aravinda M de Silva; Brian Kuhlman
Journal:  J Biol Chem       Date:  2018-04-20       Impact factor: 5.157

9.  Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008.

Authors:  Gregg N Milligan; Mellodee White; Diana Zavala; Richard B Pyles; Vanessa V Sarathy; Alan D T Barrett; Nigel Bourne
Journal:  Antiviral Res       Date:  2018-04-14       Impact factor: 5.970

10.  Regulatory T-cells in acute dengue viral infection.

Authors:  Hemadri Eresha Jayaratne; Dulharie Wijeratne; Samitha Fernando; Achala Kamaladasa; Laksiri Gomes; Ananda Wijewickrama; Graham Stuart Ogg; Gathsaurie Neelika Malavige
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.